Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristan van der Vos

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cell Reports. Medicine|April 27, 2022
Two years of pandemic: A wealth of data and many remaining questionsSara Hamilton, Isabel Goldman, Kristan van der Vos, et al.
Cell Reports. Medicine|May 5, 2021
A look back at our first yearSara Hamilton, Isabel Goldman, Kristan van der Vos, et al.
Cell Reports. Medicine|July 14, 2022
Unequal reproductive justice under the lawIsabel Goldman, Kristan van der Vos, Charlotte Owen-Woods, et al.
European Urology|March 12, 2023
Corrigendum to "Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer" [Eur Urol 2023;83:313-17]Alberto Gil-Jimenez, Jeroen van Dorp, Alberto Contreras-Sanz, et al.
European Urology|August 14, 2022
Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder CancerAlberto Gil-Jimenez, Jeroen van Dorp, Alberto Contreras-Sanz, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cell Reports. Medicine|April 27, 2022
Two years of pandemic: A wealth of data and many remaining questionsSara Hamilton, Isabel Goldman, Kristan van der Vos, et al.
Cell Reports. Medicine|May 5, 2021
A look back at our first yearSara Hamilton, Isabel Goldman, Kristan van der Vos, et al.
Cell Reports. Medicine|July 14, 2022
Unequal reproductive justice under the lawIsabel Goldman, Kristan van der Vos, Charlotte Owen-Woods, et al.
European Urology|March 12, 2023
Corrigendum to "Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer" [Eur Urol 2023;83:313-17]Alberto Gil-Jimenez, Jeroen van Dorp, Alberto Contreras-Sanz, et al.
European Urology|August 14, 2022
Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder CancerAlberto Gil-Jimenez, Jeroen van Dorp, Alberto Contreras-Sanz, et al.
Pageof 1